| Sign In to gain access to subscriptions and/or personal tools. |
Furan-Induced Hepatic Cholangiocarcinomas in Fischer 344 RatsNational Toxicology Program, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, North Carolina 27709
Southern Research, P.O. Box 55305, Birmingham, Alabama 35255
Southern Research, P.O. Box 55305, Birmingham, Alabama 35255
National Toxicology Program, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, North Carolina 27709 In a 2-yr carcinogenicity bioassay, 0, 2, 4, or 8 mg furan/kg body weight (BW) was administered to male and female Fischer (F344) rats and resulted in an 86-100% incidence of cholangiocarcinomas with occasional metastasis. In a separate but concurrent study, male F344 rats dosed with 30 mg furan/kg BW for 90 days developed marked cholangiofibrosis and cholangiohepatitis and, when subsequently maintained without further treatment for an additional 6, 12, or 18 months, the cholangiofibrosis progressed to yield a 100% incidence of cholangiocarcinomas. Transplantation of 21 primary cholangiocarcinomas into syngeneic recipients resulted in growth from 4 donors. The 4 transplanted lines were successfully transferred through 8 serial passages and resulted in metastases in the recipients. The progressive growth of these proliferative hepatocholangial lesions over time, their transplantability, and the development of metastases in some of the cases provide biological evidence of the malignant potential of the furan-induced liver changes.
Key Words: Cholangiohepatitis hepatocarcinogenesis transplantation tumor progression "stop study"
Toxicologic Pathology, Vol. 19, No. 4-2,
561-570 (1991) This article has been cited by other articles:
|
||||||||||||||||

